Longcor Jarrod 4
4 · Cellectar Biosciences, Inc. · Filed Mar 14, 2018
Insider Transaction Report
Form 4
Longcor Jarrod
Chief Operating Officer
Transactions
- Sale
Common Stock
2018-03-13$1.18/sh−13,000$15,397→ 67,000 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2017 to satisfy tax withholding obligations upon vesting of restricted stock.
- [F2]The price reported in Column 4 of Line 1 with respect to the 13,000 shares sold on March 13, 2018 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.17 to $1.21. The Reporting Person has provided to the Issuer, and undertakes to provide to any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnote (2) to this Form 4.